QLT PhotoTherapeutics Inc., Beaufour Ipsen deal

Beaufour Ipsen's Speywood Pharmaceuticals Ltd. division received exclusive European marketing and distribution rights to QLTIF's

Read the full 168 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE